Contribution of Myocardial Perfusion Imaging in the Initial Assessment of Acute Coronary Syndromes Without ST Elevation for the Diagnosis of Myocardial Infarction or Differential Diagnoses

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFondation Hôpital Saint-Joseph

About this trial

Patients with myocardial infarction require invasive treatment involving coronary angiography to confirm the diagnosis and, in most cases, treatment by angioplasty/stenting. Trans-thoracic ultrasound is central to the initial management of patients admitted to hospital with acute coronary syndrome without ST segment elevation.

The aim of our study is therefore to compare perfusion ultrasound with coronary angiography and MRI in this population in order to determine whether the performance is satisfactory.

Eligibility criteria

Qualifiers

Patient over 18 years of age

Hospitalised in cardiology as an emergency for acute coronary syndrome without ST segment elevation with indication for coronary angiography within 72 hours of admission

Not yet undergone coronary angiography.

Troponin >99th percentile, i.e. >27ng/l (troponin I, hypersensitive, Abbott)

Disqualifiers

Rhythmically unstable patient: sustained ventricular tachycardia, sudden death recovered.

Patient with a known allergy to ultrasound contrast medium

Patient with ST segment elevation.

Patient with a contraindication to MRI.

Trial design

Treatments tested in this trial

  • perfusion ultrasound

Treatment groups

No treatment groups listed